Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel Monotherapy in High Bleeding Risk PCI Patients
NCT05223335Phase 4Completed
- Sponsor
- Mayo Clinic
- Start
- Mar 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clopidogrel in coronary artery disease (CAD), sponsored by Mayo Clinic. Started Mar 2022; status: completed.
02
Drugs
clopidogrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT05223335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05223335.